Edwards Lifesciences Corporation Common Stock vs Southern Company — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.9 (market cap $48.56B), while Southern Company trades at $86.02 (market cap $99.10B). The key difference: Southern Company is far larger — about 2× Edwards Lifesciences Corporation Common Stock's market cap, and Southern Company pays a 3.53% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | SO | |
|---|---|---|
Market Cap | $48.56B | $99.10B |
Volume | 6,520,488 | 5,985,559 |
Sector | Health | Utilities |
52-Week High | $95.18 | $99.72 |
52-Week Low | $72.65 | $82.35 |
Enterprise Value | $45.01B | $173.21B |
Typical Hold Time | — | 12 Days |
Dividend Yield | — | 3.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →